Citation Impact
Citing Papers
Epigenetic Resensitization to Platinum in Ovarian Cancer
2012
DNA Hypomethylation and Ovarian Cancer Biology
2004
CpG island methylator phenotype in cancer
2004
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Cytosine methylation regulates oviposition in the pathogenic blood fluke Schistosoma mansoni
2011 Standout
Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer
2009
Microsatellite Instability in Colorectal Cancer
2010 Standout
Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
2016
Ovarian cancer
2014 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Differential Methylation Profile of Ovarian Cancer in Tissues and Plasma
2008
Cancer stem cells revisited
2017 Standout
Epigenetics in Cancer: A Hematological Perspective
2016
The Epigenomics of Cancer
2007 Standout
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Characteristic promoter hypermethylation signatures in male germ cell tumors.
2002
Molecular mechanisms of cisplatin resistance
2011 Standout
Exceptionally High Protection of Photocarcinogenesis by Topical Application of (-)-Epi gal locatechin-3-Gal late in Hydrophilic Cream in SKH-1 Hairless Mouse Model: Relationship to Inhibition of UVB-Induced Global DNA Hypomethylation
2003
Inflammation and Colon Cancer
2010 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Cisplatin resistance: Preclinical findings and clinical implications
2010
Epigenetic treatment of solid tumours: a review of clinical trials
2015
The Acquisition of hMLH1 Methylation in Plasma DNA after Chemotherapy Predicts Poor Survival for Ovarian Cancer Patients
2004
Proteases of Protozoan Parasites
1999
Cisplatin: The first metal based anticancer drug
2019 Standout
Epigenetic changes in colorectal cancer
2003
Giardia and Cryptosporidium join the ‘Neglected Diseases Initiative’
2006 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Genetics supersedes epigenetics in colon cancer phenotype
2003
The role of folate receptor α in cancer development, progression and treatment: Cause, consequence or innocent bystander?
2006
Renal cell carcinoma
2017 Standout
DNA methylation and human disease
2005 Standout
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
Cellular and molecular pharmacology of oxaliplatin.
2002
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Photoactivated platinum-based anticancer drugs
2018
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Characterization of DNA Methylation in Circulating Tumor Cells
2015
Chemical Decomposition of 5-Aza-2′-deoxycytidine (Decitabine): Kinetic Analyses and Identification of Products by NMR, HPLC, and Mass Spectrometry
2009
Works of Kim Appleton being referenced
A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer
2014
Multiple cysteine proteinases of the pathogenic protozoon Tritrichomonas foetus: identification of seven diverse and differentially expressed genes
1995
Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor Genes
2001
Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors
2007